is bydureon a glp-1 Medication Pearl of the Day: Exenatide (Bydureon) AstraZeneca's Bydureon gets a facelift,
Description
It is now licensed for use in T2D and for weight management
The MHRA and EMA include pancreatitis warnings in prescribing information, though current evidence suggests benefits generally outweigh risks in appropriately selected patients
Care should be guided by a specialist team
doi: 10.1046/j.1471-4159.1996.67051982.x
And because obesity is chronic, requiring indefinite treatment to maintain results, the lifetime value of each patient is extraordinary
Semaglutide GLP-1 aids in weight loss primarily by reducing an individuals appetite and promoting a sense of fullness for an extended period
